Clinical Trial Update: Platelet-rich Fibrin and Autogenous Bone vs Enamel Matrix Derivative and Autogenous Bone in Intrabony Defects [NA]

View source ↗

Summary

A clinical trial comparing platelet-rich fibrin with autogenous bone against enamel matrix derivative with autogenous bone for treating intrabony periodontal de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)
• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: G. d'Annunzio University | Conditions: Periodontal Bone Loss, Periodontal Attachment Loss | NA | Status: UNKNOWN